September Team Meeting
For those of you who are new to RareCan, you may not know that we recently celebrated our First Birthday. Since RareCan began and throughout the Covid Pandemic, we have been working remotely and concentrating on building our membership to the RareCan Community.
The relaxation in Covid restrictions meant we could have our first face to face meeting at our headquarters in Hexham, Northumberland. It was perfectly timed to also celebrate the MacMillan coffee morning in September.
It was great for the whole team to meet and celebrate our successes to date, as well as looking at the plans ahead for our growth in the next 12 months.
Refreshed and Revised Website
Now that you have landed on the website, we hope you will spend some time looking around.
You will see it has had a refresh in terms of content and navigation, but also, if you are using a mobile device or iPad to navigate, you will see the speed has significantly increased, which we know will improve your experience as you visit your portal and make it easier for you to upload documents.
As always, if you have any feedback for us good as well as room for improvement, please email us firstname.lastname@example.org
Enhancing your Membership Information
When you originally joined RareCan, you were given a user name and password to enable you to access your portal. A number of our members have done a great job in sharing with us key information about their cancer diagnosis, including their histology report.
You can find out more about your histology report here. The information within these reports really helps us when we are engaging with researchers who may wish to make contact with our members.
If you haven’t yet completed the sign up to your portal and updated your details you can follow this link straight to your account.
Making Headlines in the North East
Our Chief Scientific Officer, Andy Hall, featured in the Newcastle Chronicle recently.
Andy discusses the need to help researchers get together the number of patients needed to carry out their research and how RareCan supports that. You can read the full article here.
Andy will also be joining a seminar in November run by NovoPath Newcastle to discuss Improving Outcomes in Rare Cancers.
We look forward to sharing more developments with you in the New Year.